HAYWARD, Calif., Nov. 23 /PRNewswire/ -- Jeffrey Dover, MD, Director of SkinCare Physicians of Chestnut Hill in Boston, MA, and Roy Geronemus, MD, Director of the Laser & Skin Surgery Center of New York, NY, presented safety data on three years of clinical experience with the non-invasive Thermage procedure for skin tightening and facial contouring. The two cosmetic laser surgeons are world-renowned experts in researching emerging technologies and have introduced numerous advanced aesthetic innovations into clinical practice.
Speaking at the 13th Annual Congress of the European Academy of Dermatology and Venereology in Florence, Italy, Dr. Dover told colleagues that the Thermage procedure “has revolutionized my practice and expanded our patient base by allowing us to offer patients a scalpel-free alternative for achieving moderate improvement of skin laxity without the downtime of conventional face lifting techniques.”
According to Dr. Dover, more than 120,000 Thermage treatments have been performed worldwide with an estimated 99.85% of those free of any significant side effects over the last several years. Moreover, when using the most recent treatment guidelines, even rare side effects are reduced threefold, making Thermage one of the safest cosmetic procedures available today.
Dr. Dover discussed the experience of his clinic using the multiple-pass algorithm and enhanced 1.5 treatment tips. These advancements have led to observations of increased clinical predictability, more consistent skin tightening results, reduction of the already rare incidence of adverse effects, and greatly reduced patient discomfort. He reported that the use of moderate treatment-level settings with multiple passes also enables the physician to treat to a clinical endpoint of immediate visual tightening to determine the number of passes, providing immediately noticeable results to the patient of the unique contouring effects seen with Thermage.
“The recent advancements in procedure technique have made Thermage more predictable, safer, and turned pain into a non-issue with my patients,” said Dr. Dover. “Our Boston practice has successfully treated hundreds of patients with high satisfaction, and we have hundreds more people -- of all ages and skin types -- requesting this kinder, gentler and more natural approach to regaining a fresher, tighter and more youthful appearance.”
At “Advances in Aesthetic Plastic Surgery: The Cutting Edge V Symposium,” a premier educational event sponsored by Manhattan Eye, Ear and Throat Hospital and New York University Institute of Reconstructive Plastic Surgery and endorsed by the American Society for Aesthetic Plastic Surgery, Dr. Geronemus reported that he has successfully treated nearly 1,000 patients with the ThermaCool radiofrequency system. The clinical professor of dermatology at New York University Medical Center credits his success to Thermage’s proven track record of delivering safe, yet highly effective results to patients demanding an alternative to invasive cosmetic surgery.
“Many of my patients want to rejuvenate their appearance to look as young as they feel but shun an ‘extreme makeover’ or invasive surgeries involving prolonged and extensive recovery times before they see results,” said Dr. Geronemus. “What makes the Thermage procedure so attractive to these patients is that they can achieve impressive and more natural results without the lengthy downtime or potential risks of more drastic cosmetic procedures.”
Dr. Geronemus noted that the clinical observations of more consistent results, overall improved efficacy and reduced pain are supported by basic tissue science presented by Dr. Brian Zelickson, Minneapolis, MN, at recent medical meetings that showed a greater deep-collagen denaturation effect with multiple treatment passes at moderate heat settings compared to single passes at higher and more painful settings.
Bob Byrnes, Thermage’s Chief Executive Officer commented: “We are proud that Thermage has delivered and continues to provide a positive patient experience based on safety and efficacy that is well-established both in the scientific literature and the clinical practices of more than 1,200 physicians worldwide. He added: “As with any cosmetic medical procedure, patients should have realistic expectations and discuss the associated benefits and risks of treatment with their physician.”
Thermage is a leading medical device company that develops innovative aesthetic technologies, including its patented capacitive radiofrequency device, to achieve a desired cosmetic or therapeutic effect on and under the skin surface. Its flagship ThermaCool TC System is currently installed in more than 1,200 dermatology, plastic surgery and other cosmetic surgery practices worldwide. Founded in 1996, the Company’s headquarters are located in Hayward, California, proximate to the San Francisco Bay Area and the Silicon Valley.
For more information about Thermage(R) treatment, log on to http://www.thermage.com/.
Thermage
CONTACT: Nadine Tosk, +1-504-483-6957, or nadinepr@bellsouth.net, forThermage
Web site: http://www.thermage.com/